Acute Promyelocytic Leukemia - 35 Studies Found
| Completed |
: Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA) : Acute Promyelocytic Leukemia : 2007-04-25 : Drug: AIDA |
| Completed |
: Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005) : Acute Promyelocytic Leukemia : 2006-12-05 :
|
| Completed |
: Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy : Acute Promyelocytic Leukemia : 2017-01-24 : Other: QoL questionnaires Quality of life questionnaires |
| Completed |
: Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF) : Acute Promyelocytic Leukemia : 2016-09-04 :
|
| Completed |
: Role of Microparticles in the Coagulopathy of Acute Promyelocytic Leukemia : Acute Promyelocytic Leukemia : 2016-03-02 |
| Completed |
: Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia : Acute Promyelocytic Leukemia : 2007-08-16 : Drug: Single agent arsenic trioxide duration of maintenance therapy, 6 months versus 12 months |
| Completed |
: Proteasome Inhibition in Acute Promyelocytic Leukemia : Relapsed Acute Promyelocytic Leukemia : 2013-09-22 : Drug: Bortezomib Combination of arsenic trioxide with bortezomib in the treatment of relapsed acute prom |
| Recruiting |
: Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia : Acute Promyelocytic Leukemia : 2008-05-07 : Drug: NRX 195183 Soft Gelatin Capsule Daily oral NRX 195183 administration for 90 days to assess CR rate |
| Completed |
: Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia : Acute Promyelocytic Leukemia : 2016-02-11 :
|
| Completed |
: Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic :
|